Next-Generation Vibro-Acoustography Platform for Personalized Medicine and Real-Time Tissue Analysis

Publication ID: 24-11857373_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Vibro-Acoustography Platform for Personalized Medicine and Real-Time Tissue Analysis,” Published Technical Disclosure No. 24-11857373_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857373_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,373.

Summary of the Inventive Concept

A revolutionary vibro-acoustography platform that integrates hybrid transducers, machine learning-based signal processing, and cloud-based data analytics to enable real-time, label-free, and non-invasive tissue analysis and personalized medicine.

Background and Problem Solved

The original patent on multi-frequency harmonic acoustography for target identification and border detection has limitations in terms of resolution, speed, and clinical applicability. The new inventive concept addresses these limitations by introducing a hybrid transducer that combines acoustic and optical sensing, enabling real-time monitoring of tissue properties and personalized treatment plans.

Detailed Description of the Inventive Concept

The next-generation vibro-acoustography platform comprises a compact, wearable transducer array that emits and detects acoustic waves, a hybrid transducer incorporating a piezoelectric element and an optical sensor, and a machine learning-based signal processor. The platform can generate high-resolution, multi-frequency images of target tissues and provide real-time feedback on changes in tissue properties. The cloud-based database of tissue properties and machine learning-based algorithm enable personalized treatment plans and real-time monitoring of treatment efficacy.

Novelty and Inventive Step

The new claims introduce a paradigm shift in vibro-acoustography by combining acoustic and optical sensing, enabling real-time monitoring of tissue properties, and integrating machine learning-based signal processing and cloud-based data analytics. These advancements provide a significant improvement over the original patent, enabling personalized medicine and real-time tissue analysis.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as electromagnetic or thermal sensors, or the integration of other imaging modalities, such as ultrasound or MRI. Variations of the platform could be designed for specific clinical applications, such as cancer diagnosis or cardiovascular disease monitoring.

Potential Commercial Applications and Market

The next-generation vibro-acoustography platform has significant commercial potential in the fields of personalized medicine, medical imaging, and healthcare analytics. The platform could be marketed to hospitals, research institutions, and pharmaceutical companies, with potential applications in cancer diagnosis, cardiovascular disease monitoring, and neurodegenerative disease research.

CPC Classifications

SectionClassGroup
A A61 A61B8/485
A A61 A61B8/085
A A61 A61B8/4494
B B06 B06B1/0622
G G01 G01S7/52038
G G01 G01S15/8913
G G01 G01S15/8922
G G01 G01S15/8952
A A61 A61B8/5207
G G01 G01S7/5203

Field of Art

Medical imaging and diagnostic ultrasound technologies, with specialized expertise in multi-frequency acoustic imaging, transducer design, and signal processing for tissue characterization

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical imaging specialist with advanced degrees in electrical engineering or biomedical engineering, proficient in ultrasound signal processing, transducer design, and machine learning techniques for medical diagnostics

Obviousness Rationale

A person having ordinary skill would recognize that the PTD represents a predictable extension of the source patent's multi-frequency harmonic acoustography techniques by integrating machine learning, cloud-based analytics, and hybrid sensing modalities. The core acoustic imaging principles remain consistent, with the PTD introducing incremental technological improvements that would be apparent to a skilled practitioner familiar with emerging medical imaging technologies. The combination of known techniques and standard engineering design choices demonstrates the obvious nature of the disclosed variations.

Obvious Combinations & Variations

Source Patent Element
Confocal transducer with piezoelectric elements for multi-frequency ultrasonic wave generation
PTD Variation
Hybrid transducer incorporating piezoelectric and optical sensing elements with multi-modal signal detection
Obviousness Reasoning
Integrating multiple sensing modalities is a predictable engineering solution for enhanced diagnostic capabilities, representing a known technique in medical imaging for improving signal resolution and information extraction
Source Patent Element
Focused ultrasonic waves for tissue property identification
PTD Variation
Machine learning-based signal processing for real-time tissue property analysis and personalized treatment planning
Obviousness Reasoning
Application of machine learning to signal processing is a standard approach in medical imaging, representing an obvious optimization of existing diagnostic techniques using well-established computational methods
Source Patent Element
Tissue boundary detection using acoustic wave interactions
PTD Variation
Cloud-based database and analytics platform for comprehensive tissue property tracking and personalized medicine
Obviousness Reasoning
Extending localized diagnostic techniques to cloud-based data management is a predictable technological progression, utilizing standard cloud computing and big data techniques to enhance medical diagnostic capabilities
Source Patent Element
Confocal transducer with centrally positioned hydrophone
PTD Variation
Compact, wearable transducer array with integrated multi-modal sensing capabilities
Obviousness Reasoning
Miniaturization and portability of medical imaging devices is a known design optimization, representing a straightforward engineering adaptation of existing transducer technologies
Source Patent Element
Multi-frequency ultrasonic wave generation for tissue characterization
PTD Variation
Multi-modal imaging using simultaneous acoustic and optical signal generation and processing
Obviousness Reasoning
Expanding signal detection modalities is a predictable enhancement in medical imaging, representing a logical extension of existing multi-frequency imaging techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857373 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and non-patentable. The published technical disclosure demonstrates that the proposed advancements represent predictable combinations of known medical imaging techniques, signal processing methods, and computational approaches, thereby rendering subsequent claims obvious under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,373
TitleMulti-frequency harmonic acoustography for target identification and border detection
Assignee(s)The Regents of the University of California